Company Overview and News

 
New Zealand shares rise ahead of index review

2018-05-14 nzherald.co.nz
New Zealand shares rose ahead of the MSCI rebalancing tomorrow, with possible addition A2 Milk leading gains while Fletcher Building and Mercury New Zealand, rumoured to be leaving, dropped.

 
Port of Tauranga leads stockmarket higher

2018-05-07 nzherald.co.nz
New Zealand shares gained, led higher by Gentrack Group and Port of Tauranga, with Westpac Banking Corp gaining on its first-half result.

 
NZ shares mixed, A2 gains while Gentrack, Spark, bank stocks drop

2018-05-04 nzherald.co.nz
New Zealand shares were mixed, with A2 Milk pulling the index up while Gentrack Group, Spark New Zealand and banking stocks dropped.

 
NZ shares rise, Z Energy gains after annual earnings

2018-05-03 nzherald.co.nz
New Zealand shares gained, led by Z Energy following its annual results, with Chorus and Genesis also rising.

 
NZ shares up as A2 leads index

2018-05-02 nzherald.co.nz
New Zealand shares gained, with Gentrack Group hitting a record and electricity companies Mercury New Zealand and Contact Energy gaining.

 
NZ shares dip; Kiwi Property, Fletcher drop

2018-05-01 nzherald.co.nz
New Zealand shares fell slightly, despite a gain in energy stocks and ANZ Bank New Zealand rising on its first-half earnings.

 
Shares keep falling amid global sell-off

2018-03-26 nzherald.co.nz
New Zealand's S&P/NZX 50 Index fell about 1 per cent for the second straight session, joining a global selloff that started on Wall Street and extended into Asia amid fears of a trade war. Spark NZ, Air New Zealand, Sky Network Television and A2 Milk all fell.

 
MARKET CLOSE: NZ shares join global sell-off

2018-03-26 nbr.co.nz
(BusinessDesk) - New Zealand's S&P/NZX 50 Index fell about 1 percent for the second straight session, joining a global selloff that started on Wall Street and extended into Asia amid fears of a trade war. Spark NZ, Air New Zealand, Sky Network Television and A2 Milk all fell.

 
MARKET CLOSE: NZ shares hit record amidst rebalancing, Comvita and Sky TV gain while Pushpay, A2 drop

2018-03-16 nbr.co.nz
New Zealand shares rose in heavy turnover amidst index rebalancing, with Comvita and Sky Network Television gaining while Pushpay and A2 Milk Co dropped.

 
NZ shares hit record amidst rebalancing

2018-03-16 nzherald.co.nz
New Zealand shares rose in heavy turnover amidst index rebalancing, with Comvita and Sky Network Television gaining while Pushpay and A2 Milk Co dropped.

 
A2 Milk leads sharemarket higher

2018-03-12 nzherald.co.nz
New Zealand shares gained, led higher by A2 Milk Co on index inclusion speculation, with Pushpay and Kathmandu Holdings up.

 
MARKET CLOSE: NZ shares gain

2018-03-12 nbr.co.nz
(BusinessDesk) - New Zealand shares gained, led higher by A2 Milk Co on index inclusion speculation, with Pushpay and Kathmandu Holdings up.

 
MARKET CLOSE: NZ shares rise; Metro Glass rebounds ahead of index exit, Comvita falls

2018-03-09 nbr.co.nz
New Zealand shares rose, led higher by a rebounding Metro Performance Glass. Spark New Zealand gained while Comvita fell.

 
NZ shares rise; Spark gains

2018-03-09 nzherald.co.nz
New Zealand shares rose, led higher by a rebounding Metro Performance Glass. Spark New Zealand gained while Comvita fell.

 
Up 1,226 per cent: Australia's best stock is one you may have never heard of

2017-12-19 theage.com.au
Technology isn't big on the Australian sharemarket, but it has provided investors with a stock that has soared 1,226 per cent this year.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

12h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

12h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

22h - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...